Session Type
Meeting
Search Results for Outcomes
Abstract Number: 109
SHM Converge 2023
Background: Panel-based Nucleic acid amplification tests (NAATs) are laboratory tools that are used to detect small quantities of RNA or DNA to rapidly identify a multitude of infectious organisms. A systematic review and meta-analysis looking at the diagnostic accuracy of the BioFire® FilmArray® meningitis-encephalitis (ME) panel which is used at our institution showed that it […]
Abstract Number: 110
SHM Converge 2024
Background: Heatstroke is a life-threatening condition representing the most severe manifestation of heat-related illnesses. It is characterized clinically by extremely elevated body temperature, neurologic dysfunction, and multiorgan failure. Unmitigated fossil fuel use is increasing global average temperatures, which may impact the incidence of heatstroke admissions. Vulnerability to heat-related illness varies within communities based on exposure […]
Abstract Number: 110
Hospital Medicine 2020, Virtual Competition
Background: ST-segment elevation myocardial infarctions (STEMI) is a significant cause of morbidity and mortality in the United States. Inter-hospital transfers (IHT) are becoming the standard for treatment of ST-elevation myocardial infarctions (STEMIs) as specialized care is often concentrated at tertiary centers. The American Heart Association and the American College of Cardiology (AHA/ACC) recommends door-to-balloon time […]
Abstract Number: 111
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Code Blues, or in-hospital cardiopulmonary arrests, are high intensity, often fatal events occurring frequently within the hospital. National data reviews estimate that survival to discharge following an in-hospital cardiac event is about 24.4%. Further analysis has shown lower survival rates when comparing night shift physicians with day shift physicians (20.7% and 27.5% respectively), but […]
Abstract Number: 113
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Central line-associated bloodstream infection (CLABSI) is a preventable complication. In the United States, there are more than 20,000 CLABSI per year, resulting in a cost of about $30,000 per infection. A number of interventions have been employed to decrease the risk of CLABSI. Previous studies have documented the importance of simulation-based training. There is […]
Abstract Number: 117
SHM Converge 2023
Background: Proton pump inhibitors (PPIs) have been associated with adverse events and increased mortality in patients diagnosed with cirrhosis (1). PPIs are commonly prescribed to patients with cirrhosis who present to the hospital with gastrointestinal bleeds (2). However, guidelines do not suggest routine usage of PPI in patients with cirrhosis without gastroesophageal reflux disease (GERD) […]
Abstract Number: 120
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Cholangiocarcinoma is an uncommon cancer with a very bad prognosis despite advances made in treatment. Location intrahepatic versus extrahepatic – determines surgical options. In our study, we examined variations in outcomes between patients admitted to the hospital with intrahepatic versus extrahepatic disease. Methods: Data from the National Inpatient Sample (NIS) which is part of […]
Abstract Number: 121
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Introduction: Colorectal cancer is the 4th most common cancer in the United States. It is the second most common cause of death in the united states. Despite universal advocacy for screening colonoscopies and early diagnosis, disparities in screening and diagnosis of colorectal cancer exist which affects outcomes. In this analysis, we determine racial disparities […]
Abstract Number: 123
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Septic arthritis (SA) of native joints has an incidence rate of 4-12 per 100,000 person-years. In 2012, there were 36, 539 hospitalizations for SA in US non-VA hospitals and costed the US healthcare system $2.85 billion. Such data has not been reported for US VA-healthcare System. SA has a mortality of 4-13%. Among survivors […]
Abstract Number: 125
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Patients with diabetic foot ulcers (DFUs) experience large burdens of morbidity, mortality, and hospital costs. Over a third of patients with diabetes will develop DFUs in their lifetime; and almost half of these patients subsequently develop diabetic foot infections (DFIs). Although it has been reported that obese patients with diabetes do not have higher […]